24 Months Expiration Date
10/26/2023
This is to notify you that your request to update the MaximBio ClearDetect COVID-19 Antigen Home Test to extend the shelf-life expiration date to 24 months, when stored at 4oC – 30oC, based on the results of your stability studies, is granted.
View List of Kits impacted here.
MaximBio Inks Contract with National Institutes of Health (RADx) Centered on a new Rapid Platform
05/09/23
MaximBio is proud to announce it has signed a new agreement with the National Institutes of Health (NIH) through the Rapid Acceleration of…
12 Months Expiration Date Extension
01/09/23
The FDA granted a shelf-life extension for the MaximBio ClearDetect™ COVID-19 Antigen Home Test, which extended the shelf-life of all ClearDetect™ tests to 12 months. Please read more to check the most updated expiration date of your kit.
8 Months Expiration Date Extension
07/22/22
The FDA granted a two-month shelf-life extension for the ClearDetect™ COVID-19 Antigen Home Test, which extended the shelf-life of all ClearDetect™ tests from 6 months to 8 months. Please read more to check the most updated expiration…
18 Months Expiration Date
07/05/2023
On July 5, 2023, the FDA granted a shelf-life extension for the MaximBio ClearDetect™ COVID-19 Antigen Home Test, which extended the shelf-life of all ClearDetect™ tests to 18 months.
WellTree Molecular Group Joins MaximBio Team as new Distribution Partner
MaximBio Expands Sales and Marketing Organization and Adds WellTree Molecular Group as a new Distribution Partner
Maxim Biomedical, Inc. and Canon Virginia, Inc. Announce Collaboration
04/04/22
Canon Virginia, Inc. (CVI) today announces new relationship with Maxim Biomedical to assemble ClearDetect™ COVID-19 Antigen Home Test Kits.
MaximBio Signs Contract with the United State's DoD
03/29/22
MaximBio Reveals Agreement with US DoD for ClearDetect™ COVID-19 Antigen Home Test
MaximBio Receives EUA for ClearDetect COVID-19 Antigen Home Test
Maxim Biomedical Inc. Receives EUA for New ClearDetect™ COVID-19 Antigen Home Test
ACS Publications - Blind Spot Multiplex LFA Detection
08/23/21
Blind Spot: A Braille Patterned Novel Multiplex Lateral Flow Immunoassay Sensor Array for the Detection of Biothreat Agents.
MaximBio to Produce Millions of POC COVID-19 Tests
11/25/20
Maryland Company Poised to Produce Millions of Point-of-Care COVID-19 Tests that Deliver Accurate Results in 15 minutes
MaximBio Ramps Up Manufacturing of COVID-19 Tests
10/19/20
Maxim Biomedical Ramps Up Manufacturing, Completes Validation of 15-Minute SARS-CoV-2 Antigen Test
COVID-19 Results in Less than 15 minutes
09/04/20
Maxim Biomedical Inc. Rapid Antigen COVID-19 Test to Deliver Results in Less Than 15 Minutes While Reducing Risk of Exposure to Healthcare Workers
NIH Awards MaximBio Millions
The National Institutes of Health Award Maxim Biomedical Millions in Manufacturing and Scale Up Support for MaximBio SARS-CoV-2 Rapid Antigen Test
MaximBio Partners with ARM Institute
///
Siemens and partners remove barriers, scramble to help protect Americans